Citation: M. Shumway et al., STAKEHOLDER PREFERENCES FOR SCHIZOPHRENIA OUTCOMES - AN EVALUATION OFASSESSMENT METHODS, Schizophrenia research, 24(1-2), 1997, pp. 258-258
Authors:
JUAREZREYES MG
SHUMWAY M
BATTLE C
BACCHETTI P
HANSEN MS
HARGREAVES WA
Citation: Mg. Juarezreyes et al., CLOZAPINE ELIGIBILITY - THE EFFECT OF STRINGENT CRITERIA ON ETHNIC, GENDER AND AGE SUBGROUPS OF SCHIZOPHRENIC-PATIENTS, Progress in neuro-psychopharmacology & biological psychiatry, 20(8), 1996, pp. 1341-1352
Authors:
JUAREZREYES MG
SHUMWAY M
BATTLE C
BACCHETTI P
HANSEN MS
HARGREAVES WA
Citation: Mg. Juarezreyes et al., EFFECTS OF STRINGENT CRITERIA ON ELIGIBILITY FOR CLOZAPINE AMONG PUBLIC MENTAL-HEALTH CLIENTS, Psychiatric services, 46(8), 1995, pp. 801-806
Authors:
JUAREZREYES M
SHUMWAY M
BACCHETTI P
BATTLE C
HANSEN MS
HARGREAVES W
Citation: M. Juarezreyes et al., STRINGENT CLOZAPINE ELIGIBILITY CRITERIA - IMPACT ON ETHNIC, GENDER, AND AGAE SUBGROUPS OF SCHIZOPHRENIC-PATIENTS, Schizophrenia research, 15(1-2), 1995, pp. 192-192
Citation: M. Shumway et C. Battle, CLINICIAN PREFERENCES FOR SCHIZOPHRENIA OUTCOMES - A COMPARISON OF 4 METHODS, Schizophrenia research, 15(1-2), 1995, pp. 197-197